We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca Wins Patent-Infringement Suit Over Onglyza Generics for Diabetes
AstraZeneca Wins Patent-Infringement Suit Over Onglyza Generics for Diabetes
In a setback for generics makers, AstraZeneca prevailed in a patent-infringement lawsuit when a federal judge validated the company’s patent for the diabetes drug Onglyza.